CXCL1 and Alzheimer disease: Experimental evidence indicates that skullcapflavone II downregulates CXCL1 expression in MC903-induced AD mouse model, which is associated with reduced infiltration of CD4+ T cells, eosinophils, and neutrophils (Lee Y. et al., 2022).